Sorafenib moderately inhibited proliferation of A549, HeLa and HepG2 cells. Sorafenib was added to A549, HeLa, and HepG2 cells, and cultured for 72 h in culture medium, meanwhile, DMSO was added to controls. Sorafenib displayed moderate cytotoxicity to cell proliferation dose-dependently.